Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim, DH Suh, J Kim… - Gynecologic …, 2023 - Elsevier
Objectives To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …
被引用次数：3 相关文章

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim… - Gynecologic …, 2023 - snucm.elsevierpure.com
Objectives: To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim, DH Suh… - Gynecologic …, 2023 - europepmc.org
Objectives To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim, DH Suh… - Gynecologic …, 2023 - scholarworks.bwise.kr
Objectives: To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim… - Gynecologic …, 2023 - gynecologiconcology-online.net
Objectives To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim, DH Suh… - Gynecologic …, 2023 - cuk.elsevierpure.com
Objectives: To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim, DH Suh… - Gynecologic … - pubmed.ncbi.nlm.nih.gov
Objectives To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial …

AJ Lee, EJ Yang, NK Kim, Y Kim, DH Suh, J Kim… - repository.ajou.ac.kr
Objectives: To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …